» Articles » PMID: 32431110

Differences in Clinical Outcomes Between Patients with and Without Hypoglycemia During Hospitalization: A Retrospective Study Using Real-World Evidence

Overview
Specialty Endocrinology
Date 2020 May 21
PMID 32431110
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Some patients admitted to hospitals for glycemic control experience hypoglycemia despite regular meals and despite adhering to standard blood glucose control protocols. Different factors can have a negative impact on blood glucose control and prognosis after discharge. This study investigated risk factors for hypoglycemia and its effects on glycemic control during the hospitalization of patients in the general ward.

Methods: This retrospective study included patients who were admitted between 2009 and 2018. Patients were provided regular meals at fixed times according to ideal body weights during hospitalization. We categorized the patients into two groups: those with and those without hypoglycemia during hospitalization.

Results: Of the 3,031 patients, 379 experienced at least one episode of hypoglycemia during hospitalization (HYPO group). Hypoglycemia occurred more frequently particularly in cases of premixed insulin therapy. Compared with the control group, the HYPO group was older (61.0±16.8 years vs. 59.1±16.5 years, =0.035), with more females (60.4% vs. 49.6%, <0.001), lower body mass index (BMI) (23.5±4.2 kg/m² vs. 25.1±4.4 kg/m², <0.001), and higher prevalence of type 1 diabetes mellitus (6.1% vs. 2.6%, <0.001), They had longer hospital stay (11.1±13.5 days vs. 7.6±4.6 days, <0.001). After discharge the HYPO group had lower glycosylated hemoglobin reduction rate (-2.0%±0.2% vs. -2.5%±0.1%, =0.003) and tended to have more frequent cases of cardiovascular disease.

Conclusion: Hypoglycemia occurred more frequently in older female patients with lower BMI and was associated with longer hospital stay and poorer glycemic control after discharge. Therefore, clinicians must carefully ensure that patients do not experience hypoglycemia during hospitalization.

Citing Articles

Acute kidney injury: a strong risk factor for hypoglycaemia in hospitalized patients with type 2 diabetes.

Carreira A, Castro P, Mira F, Melo M, Ribeiro P, Santos L Acta Diabetol. 2023; 60(9):1179-1185.

PMID: 37173530 PMC: 10359379. DOI: 10.1007/s00592-023-02112-0.


Adherence to healthy lifestyle behaviors as a preventable risk factor for severe hypoglycemia in people with type 2 diabetes: A longitudinal nationwide cohort study.

Yun J, Han K, Park Y, Han E, Lee Y, Ko S J Diabetes Investig. 2022; 13(9):1533-1542.

PMID: 35474300 PMC: 9943249. DOI: 10.1111/jdi.13818.


Data Pseudonymization in a Range That Does Not Affect Data Quality: Correlation with the Degree of Participation of Clinicians.

Shin S, Kim H J Korean Med Sci. 2021; 36(44):e299.

PMID: 34783216 PMC: 8593412. DOI: 10.3346/jkms.2021.36.e299.


Response: Differences in Clinical Outcomes between Patients with and without Hypoglycemia during Hospitalization: A Retrospective Study Using Real-World Evidence (Diabetes Metab J 2020;44:555-65).

Lee J, Kim H Diabetes Metab J. 2020; 44(5):779-780.

PMID: 33115215 PMC: 7643592. DOI: 10.4093/dmj.2020.0215.


Letter: Differences in Clinical Outcomes between Patients with and without Hypoglycemia during Hospitalization: A Retrospective Study Using Real-World Evidence (Diabetes Metab J 2020;44:555-65).

Kim S Diabetes Metab J. 2020; 44(5):775-776.

PMID: 33115213 PMC: 7643600. DOI: 10.4093/dmj.2020.0188.

References
1.
Wild S, Roglic G, Green A, Sicree R, King H . Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27(5):1047-53. DOI: 10.2337/diacare.27.5.1047. View

2.
Kuhtreiber W, Washer S, Hsu E, Zhao M, Reinhold 3rd P, Burger D . Low levels of C-peptide have clinical significance for established Type 1 diabetes. Diabet Med. 2015; 32(10):1346-53. PMC: 4578991. DOI: 10.1111/dme.12850. View

3.
. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352(9131):837-53. View

4.
de Galan B, Zoungas S, Chalmers J, Anderson C, Dufouil C, Pillai A . Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. Diabetologia. 2009; 52(11):2328-2336. DOI: 10.1007/s00125-009-1484-7. View

5.
Foo K, Cooper J, Deaner A, Knight C, Suliman A, Ranjadayalan K . A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes. Heart. 2003; 89(5):512-6. PMC: 1767629. DOI: 10.1136/heart.89.5.512. View